Drug Res (Stuttg)
DOI: 10.1055/a-0692-2171
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Correction: In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats

Bijan Ghorbanpour Oskouei
1  Food and Drug Affairs, Tabriz University of Medical Science, Tabriz, Iran
2  Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran
,
Soheil Abbaspour-Ravasjani
3  Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
,
Seyed Jamal Musavinejad
4  Islamic Azad University, Tabriz Branch, Faculty of Veterinary Medicine, Tabriz, Iran
,
Seyed Ahmad Salehzadeh
5  Department of Medicinal Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
,
Alireza Abdolhosseinzadeh
6  Young Researchers and Elite Club, Bonab Branch, Islamic Azad university, Bonab, Iran
,
Hamed Hamishehkar
7  Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
,
Kazem Ghahremanzadeh
8  Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran
,
Behrooz Shokouhi
8  Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran
› Author Affiliations
Further Information

Publication History

Publication Date:
24 August 2018 (online)

Erratum

In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats

Bijan Ghorbanpour Oskouei, Soheil Abbaspour-Ravasjani, Seyed Jamal Musavinejad et al.

Drug Res 2018, DOI: 10.1055/a-0646-3803

The institute affiliations of Soheil Abbaspour-Ravasjani and Hamed Hamishehkar has been corrected.